Production (Stage)
Hoth Therapeutics, Inc.
HOTH
$1.19
-$0.11-8.46%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -3.48M | -2.38M | -2.13M | -1.63M | -2.15M |
| Total Depreciation and Amortization | 4.40K | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.07M | 500.00 | 283.30K | 7.10K | 513.90K |
| Change in Net Operating Assets | -387.00K | 354.40K | 214.20K | 33.70K | -91.40K |
| Cash from Operations | -2.79M | -2.03M | -1.63M | -1.59M | -1.72M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 7.07M | 1.06M | 0.00 | 3.68M | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 7.07M | 1.06M | 0.00 | 3.68M | -- |
| Foreign Exchange rate Adjustments | -500.00 | -16.60K | 2.50K | 1.60K | -5.80K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 4.28M | -983.80K | -1.63M | 2.09M | -1.73M |